Total
0
Shares
Australian first: Little Green Pharma (ASX: LGP) sends medicinal cannabis oils to Germany
Source: Little Green Pharma
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Medicinal cannabis company Little Green Pharma (LGP) has welcomed the Therapeutic Goods Administration's (TGA) regulatory changes to cannabidiol (CBD)
  • The TGA has down-scheduled some CBD products and also increased the daily maximum dosage limit
  • This decision means from early next year registered CBD products can be dispensed over-the-counter without the need for a prescription
  • LGP has congratulated the TGA for the change, stating the down-scheduling will make medicinal cannabis more widely available across Australia
  • Shares in Little Green Pharma have ended the day down a slight 0.83 per cent trading at 59.5 cents each

Little Green Pharma (LGP) has welcomed the Therapeutic Goods Administration's (TGA) wide-ranging changes to cannabidiol (CBD) regulation.

The medicinal cannabis business has joined other ASX-listed companies in congratulating the TGA for making changes to the rules around dispensing CBD.

The regulatory body has down-scheduled some CBD products to pharmacist-only medications and increased the daily maximum dosage limit to 150 mg per day.

It's an important change, as the down-scheduling means from early next year registered CBD products can be dispensed over-the-counter without the need for a prescription.

Commenting on the TGA’s decision, Little Green Pharma Managing Director Fleta Solomon said the change should benefit the entire industry.

"This final scheduling decision demonstrates both the TGA’s commitment to patient safety and product quality as well as its appreciation of prescriber and patient needs," Fleta said.

"We wish to congratulate the TGA on its decision and look forward to the significant benefits it will bring to both Australian patients and prescribers and the Australian medicinal cannabis industry as a whole."

As well as congratulating the TGA for its decision, Little Green has also flagged plans to potentially register one or two of its cannabis oil medicines.

The company said the TGA's planned increase of the maximum daily dose will give it more confidence to progress down the path of Australian Register of Therapeutic Goods (ARTG) CBD medicine registrations.

Shares in Little Green Pharma have ended Wednesday's session down 0.83 per cent at 59.5 cents each.

LGP by the numbers
More From The Market Herald
Creso Pharma (ASX:CPH) - Creso Pharma - The Market Herald

" Creso Pharma (ASX:CPH) launches ecommerce channels, enters Polish markets

Creso Pharma (CPH) has launched new e-commerce channels and expanded into Poland with a maiden purchase order secured.
Emyria (ASX:EMD) contracts consultant for psychedelics and MDMA research

" Emyria (ASX:EMD) contracts consultant for psychedelics and MDMA research

Emyria (EMD) has appointed a consultant to support its psychedelic-assisted therapy programs.
AnteoTech (ASX:ADO) - CEO, Derek Thomson - The Market Herald

" AnteoTech (ASX:ADO) ticks off another distribution deal for EuGeni

AnteoTech (ADO) has signed a distribution agreement with Ramma Dental for its EuGeni Reader platform and SARS-CoV-2 Antigen Rapid Diagnostic Test (RDT).
Healthia (ASX:HLA) - CEO, Wesley Coote - The Market Herald

" Healthia (ASX:HLA) up on Rothwell Physiotherapy buy

Healthia (HLA) shares have enjoyed a 10 per cent rise after reporting a $1.62 million acquisition of Queensland’s Rothwell Physiotherapy.